Saptamrit Lauh: Traditional Uses, Evidence & Safety

TL;DR

Saptamrit Lauh ("the seven nectars of iron") is a classical herbo-mineral formula: Triphala, Yashtimadhu, and Lauha Bhasma (calcined iron), taken with ghee and honey. Bhaishajya Ratnavali recommends it for Timira: eye disorders including myopia. A 100-patient randomized placebo-controlled study reported significant improvement in headache, eye strain, and visual acuity over 3 months. Single-center, unblinded, and symptom-based: promising, not proven.

What it is

Saptamrit Lauh is a Lauha kalpana: a formulation whose chief ingredient is Loha (iron) as Lauha Bhasma. (Spelled variously Saptamrita Lauha, Saptamruta Lauha, or Saptamrit Lauh.) The seven components: Haritaki, Vibhitaki, Amalaki (together Triphala), and Yashtimadhu (licorice). Plus Lauha Bhasma. With Madhu (honey) and Ghrita (ghee) as the vehicle (anupana). The classical reference is Bhaishajya Ratnavali, Netra Rogadhikara, where Govinddas Sen recommends it for Timira (WJPSR, 2025).

Its Ayurvedic logic: the ingredients are collectively Tridosh Shamaka and Chakshushya (beneficial to the eyes), with Triphala's antioxidant content and Lauha Bhasma's iron as the material basis.

Traditional use

Beyond Timira (myopia and other vision disorders), classical texts list Saptamrit Lauh for eye burning and itching, night blindness, premature greying, anemia, digestive complaints, urinary obstruction, cough, and general weakness. The eye indications are the primary classical use; the rest are secondary attributions.

What modern research says

Myopia trial (randomized, placebo-controlled)

One hundred patients aged 12–25 with simple developmental myopia (−0.25D to −6D) were registered and divided into two groups of 50. One group received Saptamrita Lauha 500 mg twice daily with ghrita and madhu (the discussion also mentions milk, dugdha, as vehicle). The other received arrowroot powder as placebo, for 3 months. The trial drug was purchased from Dabur Ayurvedic Pharmaceuticals. Five placebo-group patients discontinued against medical advice, so the reported results are for 95 completers (50 trial, 45 placebo).

After 90 days, the trial group showed: 15 patients (30%) cured by the authors' definition (full naked-eye Snellen-chart reading), 9 (18%) moderate improvement, and 15 (30%) mild improvement. Eleven (22%) had no improvement. In the placebo group, only 3 of 45 (7%) had mild improvement; 42 (93%) had none. Mean symptom scores improved for headache (70% relief), eye strain (24%), and visual acuity grade (24%). Each result had p<0.001 (randomized controlled study, World J Pharmaceutical Science and Research, 2025) (full text).

Important methodological limits. The randomization method is not described. Blinding is not described. The p-values come from paired t-tests comparing before-vs-after within each group, not a direct statistical comparison of trial vs. placebo. And the placebo dose is stated inconsistently (500 mg vs. 3 g twice daily in different sections). Single center, and published in a low-tier journal. Treat as encouraging preliminary evidence, not proof.

What the evidence does not support (yet)

The non-eye indications (anemia, digestion, urinary complaints, greying) have no modern study behind them. No pharmacological or toxicological studies of the formulation were identified.

Safety & contraindications

No systematic safety data for Saptamrit Lauh were identified; the myopia trial included withdrawal criteria for adverse effects but reported no adverse events, and systematic safety monitoring is absent. As an iron-containing preparation, it should be treated with the standard cautions for iron. Keep away from children (iron overdose is dangerous). Avoid in iron-overload conditions. Use only properly manufactured Lauha Bhasma: the safety of any bhasma depends on correct classical preparation. No data on pregnancy, breastfeeding, or drug interactions.

FAQs

What is Saptamrit Lauh?

A classical Ayurvedic eye formula of Triphala, licorice, and calcined iron (Lauha Bhasma), taken with ghee and honey. Bhaishajya Ratnavali recommends it for Timira (vision disorders).

Does research support Saptamrit Lauh for myopia?

One 95-completer randomized placebo-controlled trial reported improvement in headache, eye strain, and visual acuity over 3 months (30% "cured," 30% mild, 18% moderate improvement). But the statistics were within-group only, with no described randomization method or blinding: promising, not conclusive.

Is it safe?

No systematic safety studies exist. The single trial reported no adverse events, but its safety monitoring was not systematic. So the absence of evidence here is not evidence of safety. As an iron-containing bhasma it demands proper manufacture and practitioner supervision. Especially for children.

The clinical trial used 500 mg twice daily with ghee and honey for 3 months. Classical texts give 1–2 g (Bhaishajya Ratnavali) or 2–3 ratti in other references. These are trial and classical figures, not personal recommendations. Dosing should follow a qualified practitioner.

Annotated Sources

The composition (Triphala, Yashtimadhu, Lauha Bhasma with Madhu and Ghrita), the Bhaishajya Ratnavali reference, and the 100-patient randomized placebo-controlled myopia trial (500 mg BD, 3 months, p<0.001 for headache/eye strain/visual acuity) are from Sahu & Agrahari, "A Clinical Study on the Effect of Saptamruta Lauha in the Management of Timira, with Special Reference to Simple Developmental Myopia," World Journal of Pharmaceutical Science and Research 4(5), 2025 (full text). The AFI listing and classical dose references are reviewed in "A Review Study of Saptaamrita Lauha," Int J Ayu Pharm Chem (PDF).

Note: Triphala, Amalaki, and Yashtimadhu — the other botanical ingredients — do not yet have their own articles on this site.

Disclaimer

This article is for educational purposes only and is not medical advice. Saptamrit Lauh has one encouraging but limited clinical trial for myopia and no systematic safety data; it is an iron-containing bhasma preparation. Talk to a qualified healthcare practitioner before use — especially if pregnant, breastfeeding, giving it to a child, managing a medical condition, or taking prescription medicines.